Evercore ISI maintains Sherwin-Williams stock rating at outperform

Evercore ISI maintained its outperform rating and $400 target on Sherwin-Williams ahead of its Oct. 27 Q3 report, projecting 2027 EPS of $13.40 and double-digit growth without a housing recovery; it expects about 50% realization of the September price increase. The firm cited subdued volumes and higher oil and raw-material costs, while viewing Sherwin-Williams as preferred exposure to a possible 4% home-improvement market growth rate in 2028. Home Depot reported Q2 comparable sales growth of 1.7% and maintained FY2026 guidance of flat to 2% growth; analyst views on the stock remained mixed.

Analysis

The key divergence is pricing power versus demand dependence. If SHW can realize price increases while volumes remain subdued, it may protect earnings better than retailers whose near-term growth depends on transaction activity and mix. But input-cost inflation is only beneficial to SHW if price realization keeps pace without accelerating volume losses; another increase is a hypothesis, not proof of pass-through. Its industrial/commercial exposure helps diversify housing weakness, though it also leaves earnings sensitive to broader activity.

HD’s modest sales momentum alongside decelerating pricing leaves less room to offset weak unit demand through ticket growth. That is a relative margin-risk signal, not evidence of a sharp demand break: stable tracker data and maintained guidance argue against extrapolating a near-term collapse. LOW’s appliance pricing exception should be treated as a narrow category datapoint, not a read-through to its whole business.

Over the next few days, SHW’s earnings are the catalyst; look for realized price, volume, raw-material commentary, and guidance rather than the rating narrative. Over 1–3 months, the question is whether costs rise faster than realized pricing and whether home-improvement demand stabilizes. Over 6–18 months, a housing recovery could broaden SHW’s upside, but the recovery timing is uncertain. Contrarian risk: investors may overvalue pricing resilience if persistent input inflation eventually erodes margins or prompts customer substitution.

Key Decisions for Investors

• Avoid adding to SHW solely on the analyst thesis ahead of earnings. Treat the report as a confirmation event: constructive if pricing realization offsets cost pressure without further volume deterioration; reassess if management signals weaker price capture or margin pressure.
• Consider a modest SHW-versus-HD relative-value position only if earnings confirm the pricing-versus-demand divergence. Keep exposure limited: SHW is not insulated from housing or industrial weakness, and no valuation or consensus data here establishes an attractive absolute entry.
• For HD, do not short on decelerating pricing alone while guidance is maintained. Watch comparable-sales composition, gross-margin direction, and any guidance change; weakening sales plus margin compression would make the downside case more actionable.
• Falsifiers: SHW reports poor price realization, accelerating volume declines, or cost inflation outpacing pricing; alternatively, a meaningful improvement in HD demand and margins would weaken the relative-value thesis. Verify company commentary and reported metrics rather than relying on analyst estimates.